Based on the CGGA and TCGA databases, independent predictors such as WHO grade, age, IDH mutation status, 1p19q co-deletion, and EMP3 expression level were incorporated into the prognostic model as shown in Fig. 4A, B, to predict the survival of glioma patients. This evidence concerns the gene EMP3 and glioma.